Jermod Mccoy and the 2nd-Round Health Question That Could Reshape the Draft

Jermod McCoy is now more than a talent evaluation. He is a medical decision that could ripple through the draft. The University of Tennessee cornerback missed all of last season with a torn ACL in his right knee, yet his name remains in the center of a growing debate: how much risk will teams absorb for a player viewed as first-round caliber, but facing concern over another surgery and a potentially extensive recovery?

Why Jermod McCoy matters now

The timing makes this more than a routine pre-draft concern. Team medical staffs are worried McCoy could need another surgery to repair a bone plug in his knee, and that possibility changes how clubs view both his short-term availability and long-term value. The issue is not the ACL reconstruction itself. The concern centers on the bone plug used to repair a cartilage defect, which raises the possibility of a longer rehabilitation path. For teams searching for cornerback help, that is a difficult balance to strike.

McCoy’s profile still carries obvious appeal. He is rated as one of the top cornerback prospects and a likely first-round pick, but health uncertainty can move even elite talent down the board. That is why his situation is being watched so closely by teams with clear needs in the secondary. The central question is not whether the talent is there. It is whether a team is willing to trust the medical outlook enough to act early.

Jermod Mccoy and the medical risk beneath the board

There is a practical reason the concern has immediate draft consequences. One report noted that McCoy could miss “extensive” time in 2026 as a rookie in the NFL if the recovery becomes more complicated. That possibility makes him a harder projection for teams that need help right away. It also opens the door for a slide, even for a player widely viewed as one of the best at his position.

The comparison that keeps surfacing is Will Johnson, who fell out of the first round last year before going to the Cardinals at No. 47 overall amid knee-related concerns. That example matters because it shows how medical questions can alter draft value without erasing it. McCoy could follow a similar path if teams remain uneasy about the knee. In that sense, his draft range is being shaped as much by caution as by film.

His workout numbers still help explain why the upside remains so high. At Tennessee’s Pro Day last month, McCoy ran a 4. 37 in the 40-yard dash and posted a 38-inch vertical along with a 10-foot, 7-inch broad jump. Those marks reinforce the idea that his athletic ceiling has not disappeared. But teams do not draft ceilings alone. They draft timelines, and right now the timeline is the source of the uncertainty.

What the experts are signaling

Tom Pelissero of NFL Media said team medical staffs are concerned McCoy could need another surgery to repair the bone plug in his knee, which would be an extensive recovery. That is the key public signal driving the conversation. It does not close the door on McCoy’s draft value, but it does narrow the range of outcomes. A player once viewed as a straightforward premium selection now comes with a question attached to every projection.

Matt Miller’s latest mock draft added another layer to that picture, placing McCoy as a top-10 talent who slipped because of long-term knee questions. Miller wrote that McCoy ranked as his No. 10 overall prospect based on film study, but that concerns over the knee following an ACL injury in January 2025 caused him to fall. That assessment captures the tension around him: the film says premium talent, while the medical file says patience.

Draft fallout for cornerback-needy teams

For teams looking at the second round, McCoy creates both temptation and caution. One club in particular is positioned to weigh that risk because cornerback remains a need and the opportunity cost is real. If medical confidence is high, McCoy could become a major value play. If it is not, teams may prefer a safer path and let him slide further than his talent would otherwise justify.

That is the broader lesson here. Jermod McCoy is not simply a prospect with injury history; he is a test case for how much modern draft strategy is shaped by medical uncertainty. The difference between a bargain and a miss can turn on one report, one scan, or one surgery. If clubs decide the knee is manageable, he could still land as a major steal. If they do not, his fall could become the draft’s clearest reminder that talent alone does not decide the board.

So the question remains: when the clock starts and the medical risk is still unresolved, who is willing to bet on Jermod Mccoy?